SRNE (SRNE): Results for Last 10 Financial Years (Summary)

Sorrento Therapeutics, Inc.

NASDAQ (USD): Sorrento Therapeutics, Inc. (SRNE)

Last Price

0.001

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.001

Trading Volume

5,497

Financial

Market Cap

0 Million

Shares Outstanding

551 Million

Latest Quarter

30-Jun-2023 [Q2]

Announcement Date

11-Aug-2023

Reported Currency

USD

Revenue QoQ | YoY

-7.54% | 31.10%

NP QoQ | YoY

31.80% | 56.63%

Latest Audited

31-Dec-2022

Announcement Date

15-Mar-2023

Reported Currency

USD

Revenue | Net Profit

62,839,000.00 | -572,843,000.00

EPS | EPS Diluted

-1.37 Cent | -1.37 Cent

YoY

-33.53%

NP Margin

-911.60%

Reported Currency in USD

Show?

YoY %

Horiz. %

	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	31/12/13	CAGR
Last 10 FY Result (Thousand)
Revenue	62,839	52,904	39,986	31,432	21,193	151,856	8,152	4,590	3,825	460	72.63%
YoY %	18.78%	32.31%	27.21%	48.31%	-86.04%	1,762.81%	77.60%	20.00%	731.52%	-	-
Horiz. %	13,660.65%	11,500.87%	8,692.61%	6,833.04%	4,607.17%	33,012.17%	1,772.17%	997.83%	831.52%	100.00%	-
PBT	-561,747	-462,528	-310,580	-359,576	-213,781	15,315	-64,833	-13,760	-36,359	-21,911	43.36%
YoY %	-21.45%	-48.92%	13.63%	-68.20%	-1,495.89%	123.62%	-371.17%	62.16%	-65.94%	-	-
Horiz. %	2,563.77%	2,110.94%	1,417.46%	1,641.08%	975.68%	-69.90%	295.89%	62.80%	165.94%	100.00%	-
Tax	-2,416	-33,516	-2,014	-473	-6,274	-36,038	-896	36,314	-1,702	10	-
YoY %	92.79%	-1,564.15%	-325.79%	92.46%	82.59%	-3,922.10%	-102.47%	2,233.61%	-17,120.00%	-	-
Horiz. %	-24,160.00%	-335,160.00%	-20,140.00%	-4,730.00%	-62,740.00%	-360,380.00%	-8,960.00%	363,140.00%	-17,020.00%	100.00%	-
NP	-572,843	-429,012	-308,566	-359,103	-203,540	9,061	-60,923	-45,811	-34,657	-21,911	43.67%
YoY %	-33.53%	-39.03%	14.07%	-76.43%	-2,346.33%	114.87%	-32.99%	-32.18%	-58.17%	-	-
Horiz. %	2,614.41%	1,957.98%	1,408.27%	1,638.92%	928.94%	-41.35%	278.05%	209.08%	158.17%	100.00%	-
Tax Rate	-	-	-	-	-	235.31%	-	-	-	-	-
YoY %	-	-	-	-	-	0.00%	-	-	-	-	-
Horiz. %	-	-	-	-	-	100.00%	-	-	-	-	-
Total Cost	635,682	481,916	348,552	390,535	224,733	142,795	69,075	50,401	38,482	22,371	45.01%
YoY %	31.91%	38.26%	-10.75%	73.78%	57.38%	106.72%	37.05%	30.97%	72.02%	-	-
Horiz. %	2,841.54%	2,154.20%	1,558.05%	1,745.72%	1,004.57%	638.30%	308.77%	225.30%	172.02%	100.00%	-

	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	31/12/13	CAGR
Ratio Analysis
NP Margin	-911.60	-810.93	-771.69	-1,142.48	-960.41	5.97	-747.34	-998.06	-906.07	-4,761.79	-16.77%
YoY %	-12.41%	-5.08%	32.45%	-18.96%	-16,187.27%	100.80%	25.12%	-10.15%	80.97%	-	-
Horiz. %	19.14%	17.03%	16.21%	23.99%	20.17%	-0.13%	15.69%	20.96%	19.03%	100.00%	-

	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	31/12/13	CAGR
Per Share
EPS	-1.37	-1.46	-1.34	-2.56	-1.92	0.13	-1.21	-1.24	-1.30	-1.46	-0.70%
YoY %	6.16%	-8.96%	47.66%	-33.33%	-1,576.92%	110.74%	2.42%	4.62%	10.96%	-	-
Horiz. %	93.84%	100.00%	91.78%	175.34%	131.51%	-8.90%	82.88%	84.93%	89.04%	100.00%	-
EPS Diluted	-1.37	-1.46	-1.34	-2.56	-1.92	0.13	-1.21	-1.24	-1.30	-1.46	-0.70%
YoY %	6.16%	-8.96%	47.66%	-33.33%	-1,576.92%	110.74%	2.42%	4.62%	10.96%	-	-
Horiz. %	93.84%	100.00%	91.78%	175.34%	131.51%	-8.90%	82.88%	84.93%	89.04%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 1 of 1 comments

donn

buy stop 8.53

2020-09-17 04:14

Latest Videos